Efficacy and safety of extrafine glycopyrronium bromide pMDI (CHF 5259) in COPD patients - London 2016

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

International Congresses London 2016

Novel avenues in the treatment of COPD I

Chair(s): Paul Kirkham (Wolverhampton, United Kingdom), Alexander Mathioudakis (Liverpool, United Kingdom), Kian Fan Chung (London, United Kingdom), Nicolas Roche (Paris, France)

Session type: Thematic Poster

Efficacy and safety of extrafine glycopyrronium bromide pMDI (CHF 5259) in COPD patients

Mario Scuri (Parma, Italy), Elzbieta Hajol, Annalisa Piccinno, Isabelle Viaud, Isabella Montagna, Alessandro Guasconi, Stefano Vezzoli, Mario Scuri, Mike Polkey

EVENTS HOME

Limited Access

Please log in to myERS to view this content.

Don't have a myERS account? Register

Note: consult the ERS Respiratory Channel access rights page for more details.

CDN Connection Issue

The ERS International Congress 2016, London

Limited Access

#{title}